However, the effects of GLP-1 therapy create measurable changes in several key health markers that your physician will track to monitor your progress
In trials, cholelithiasis was reported in 1.1% of tirzepatide-treated patients and 1% of placebo-treated patients, and cholecystitis was seen in 0.7% and 0.2%, respectively
Demand is growing fast, and most employers face the same difficult choice: cover the drugs and absorb open-ended pharmacy costs, or withhold access and frustrate employees who need support
If anyone can find it for you, its us
Over 90% of participants in the 12mg group lost at least 10% of their body weight
In comedogenic testing, Beeswax scored a 0-2, which is on the low end